家长专区

海外疫情
美国
日本
英国
加拿大
欧洲
澳洲
新加坡
国际学校
北京
上海
广州
深圳
成都
武汉
西安
苏州
其他
留学置业
美国
英国
加拿大
澳洲

美国20亿美元快速新冠病毒检测计划

  • 责任编辑:siyu.zhang
  • 来源:互联网
  • 时间:2021-09-14 22:36:18

  新冠病毒仍是美国人的噩梦,那么现在新冠检测快吗?新冠疫苗接种效果如何?

  乔·拜登的20亿美元快速检测计划呼吁亚马逊、克罗格和沃尔玛打折进行新冠检测

  肯·奥塔克《今日美国》

  作为乔·拜登总统大幅增加检测的计划的一部分,消费者很快就可以在亚马逊、克罗格和沃尔玛获得打折的冠状病毒检测。

  拜登政府表示,这三家主要零售商将在未来三个月内“按成本价”销售快速、非处方检测产品,在零售价的基础上最高可打35%的折扣。

  拜登的战略要求花费近20亿美元,为长期护理机构、社区检测点、无家可归者收容所、监狱和其他弱势群体采购2.8亿份快速检测。另外2500万份免费的家庭快速检测将送往社区卫生中心和食品银行。

  各公司表示,由于德尔塔变型驱动的需求越来越高,制造商竞相跟上步伐,因此需要联邦政府的支持来扩大测试选项。

  测试制造商Intrivo的联合首席执行官罗恩•古特曼(Ron Gutman)表示:“目前,整个市场都存在严重短缺。”“我们的需求比以往任何时候都要大。”

  Intrivio是Access Bio的技术和业务合作伙伴,Access Bio是美国食品和药物管理局授权直接向消费者销售家庭测试的六家公司之一。由雅培(Abbott Laboratories)、Quidel和Ellume公司生产的快速抗原检测试剂盒已经在主要零售商那里销售了几个月,价格从12美元到40美元不等。Intrivio/Access Bio预计将在未来几周开始销售零售快速测试。

  销售直接面向消费者检测仪器的私营公司正争先恐后地再次增加快速检测仪器的生产。

  今年6月,Abbott警告投资者,对检测的需求“大幅下降”,并关闭了位于伊利诺伊州格尼的一家生产检测产品的工厂,此举导致2000个工作岗位被裁减。Abbott BinaxNow是Abbott BinaxNow快速抗原检测产品的生产商。最近,雅培表示将再次进行更多测试。这些工具包定期在各大零售商店有售。

  Ellume首席执行官肖恩·帕森斯(Sean Parsons)表示,公司将改为24小时生产,以便在澳大利亚的生产基地进行大量测试。该公司与美国国防部达成了2.318亿美元的协议,扩大在美国的生产。该公司计划年底前在马里兰州开设一家工厂。

  帕森斯表示:“我们当然希望在安全的情况下尽快增加产量。”

  州和地区卫生官员协会(Association of State and regional Health Officials)首席医疗官马库斯·普莱西亚(Marcus Plescia)说,除了接种疫苗和戴口罩,检测仍然是遏制冠状病毒传播的重要工具。

  Plescia说,在今年将有限的资源用于新冠疫苗接种之后,各州再次为居民增加了检测选项。

  普莱西娅说,快速家庭检测很受消费者欢迎,也更容易检查他们的状态,但检测也更难跟踪,因为结果往往没有报告给州和地方公共卫生部门。

  普莱西娅说:“如果你的检测结果呈阳性,你必须做正确的事情:待在家里,限制与他人的交流,如果你和其他人在一起,让他们知道。”“公共卫生部门会为你这么做,但前提是我们知道你的检测呈阳性。”

  其他人担心,即使拜登承诺扩大测试,成本仍将是一些人面临的障碍。虽然医疗保险公司被要求承担实验室检测和一些快速抗原检测的费用,但消费者直接从零售商购买检测时可能得不到补偿。

  “美国的检测更昂贵——这确实导致了检测的障碍,”北卡罗来纳州教授兼卫生系统专家Julie Swann博士说。

  斯旺以英国对儿童的常规筛查为例,称其为国家检测项目,“对减少传播产生了巨大影响”。

  拜登的计划可能需要广泛的测试,而不仅仅是消费者可以在零售商店购买的快速测试。联邦劳工部职业安全与健康管理局将制定一项规定,要求拥有100名或以上员工的企业强制接种疫苗或要求每周进行检测。

  许多雇主已经要求员工在进入办公室或生产现场之前定期接受检测,而检测的增加使得检测制造商争相满足需求。

  古特曼说:“我们确实在夜以继日地工作,以增加产能。”“我们认为,迫切需要将更多测试推向市场。”

  肯·奥塔克的推特账号是@kalltucker,也可以发邮件到alltuck@usatoday.com。

  附上原文,以供参考,拒绝转载,侵权必删:

  Joe Biden's $2B rapid testing plan calls for discounted COVID tests at Amazon, Kroger and Walmart

  Ken Alltucker USA TODAY

  Consumers could soon get discounted coronavirus tests at Amazon, Kroger and Walmart as part of President Joe Biden's plan to significantly increase testing.

  The Biden administration said those three major retailers over the next three months will sell rapid, over-the-counter tests "at cost," a discount of up to 35% from retail prices.

  Biden's strategy calls for spending nearly $2 billion to procure 280 million rapid tests for long-term care facilities, community testing sites, homeless shelters, prisons and other vulnerable populations. Another 25 million free at-home rapid tests would be sent to community health centers and food banks.

  Companies say federal support to expand testing options is needed as the delta variant drives demand higher and manufacturers scramble to keep pace.

  "There is a big shortage in the market right now across the board," said Ron Gutman, co-CEO of Intrivo, a testing manufacturer. "We have a lot more demand than we’ve ever seen before."

  Intrivio is the technology and business partner of Access Bio, one of six companies with Food and Drug Administration authorization to sell home tests directly to consumers. Rapid antigen tests made by Abbott Laboratories, Quidel and Ellume have been sold for months by major retailers, ranging in price from about $12 to $40 a test. Intrivio/Access Bio expect to begin selling retail rapid tests in the coming weeks.

  Private companies that sell direct-to-consumer tests are scrambling to again ramp up production of rapid tests.

  In June, Abbott, which makes versions of the Abbott BinaxNow rapid antigen test, warned investors of "significantly lower" demand for tests and closed a factory in Gurnee, Illinois, that manufactured the tests, a move that eliminated 2,000 jobs. More recently, Abbott said it was again working to produce more tests. The kits have been available periodically at major retail stores.

  Ellume CEO Sean Parsons said the company is moving to 24-hour production to churn out tests at the company's manufacturing site in Australia. The company, which secured a $231.8 million Defense Department deal to expand U.S. production, plans to open a factory in Maryland by the end of the year.

  "We’re certainly looking to increase production as swiftly as we safely can," Parsons said.

  Along with vaccination and wearing masks, testing remains an important tool to contain the spread of coronavirus, said Marcus Plescia, chief medical officer of the Association of State and Territorial Health Officials.

  Plescia said states are once again adding testing options for residents after steering limited resources to vaccination this year.

  Rapid home tests are popular with consumers and make it easier to check their status, but Plescia said the tests also are more difficult to track because results are often not reported to state and local public health departments.

  "If you do test positive, you’ve got to do the right thing: stay at home, limit your interactions with other people, and if you’ve been around other people, let them know," Plescia said. "The public health departments will do that for you, but only if we know you have tested positive."

  Others worry that even with Biden's pledge to expand testing, cost will remain a barrier for some. While health insurance companies are required to cover the cost of laboratory-based tests and some rapid antigen tests, consumers might not be reimbursed when they buy tests directly from retailers.

  "The tests in the United States are more expensive – that does lead to barriers in testing," said Dr. Julie Swann, a North Carolina State professor and health systems expert.

  Swann cited Great Britain's routine screening of children as the example of national testing program that has "had a huge impact on reducing transmission."

  The Biden plan probably will require a wide variety of tests, not just rapid tests consumers can purchase at retail stores. The federal Department of Labor's Occupational Safety and Health Administration will develop a rule requiring businesses with 100 or more employees to mandate vaccinations or require weekly testing.

  Many employers already require workers to be tested regularly before entering an office or a manufacturing site, and the increased testing has testing manufacturers scrambling to meet demand.

  "We are literally working around the clock to increase capacity," Gutman said. "We feel there is an urgency around getting more tests to market."

  Ken Alltucker is on Twitter as @kalltucker or can be emailed at alltuck@usatoday.com.

  Source of articles:https://www.usatoday.com/

  Author:Ken Alltucker


  • 国际名校 金牌文凭 不出国门 国内就读

  • 2022年U.S.News全美研究生排名

  • 快速测出真实留学语言水平,定制提分方案!

  • 天道海外置业:留学、移民等多重海外生活定

    < >
    • 留学评估
    • 语言评测

    免费留学评估
    我 是学生家长
    • 姓 名
    • 所在城市
    • 手 机
    • 意向国家
    • 邮 箱
    • 教育阶段
    • Q  Q
    • 留学目标
    • 微信号
    • 意向专业
    立即获得免费留学规划

    在线帮助

    关于我们

    专家分享

    客户案例

    合作与互动